Safety and Efficacy Evaluation of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With AMI

NCT02439398 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

55

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myocardial Infarction

Interventions

BIOLOGICAL: Allogeneic human cardiac stem cells (CSCs)
OTHER: Human Serum Albumin-HSA 5%

Sponsor

Coretherapix

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]